Source
From SEC EDGAR
170 releases originally issued via SEC EDGAR. The issuing organizations are responsible for their content.
SiTime Reports Third Quarter 2026 Financial Results
Q3 Net Revenue Increased 257% to $298.7 Million
ParkOhio Announces Record Sales and Strong Third Quarter 2026 Results;
Raises FY 2026 Sales and Adjusted EPS Outlook on Continued Strong Demand Across Its Diversified End Markets
Vaxcyte Reports Third Quarter 2026 Financial Results and Provides Business Update
VAX-31 Adult Indication: Announced Positive Topline Data from OPUS-1 Pivotal Phase 3 Trial; VAX-31 Met All Prespecified Primary Endpoints, Was Well…
e.l.f. Beauty Announces Second Quarter Fiscal 2027 Results
– Delivered 51% Net Sales Growth –
OPKO Health Reports Third Quarter 2026 Business Highlights and Financial Results
Conference Call to Begin Today at 4:30 p.m. ET
Tenaya Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Received Regenerative Medicine Advanced Therapy (RMAT) Designation from U.S. FDA for TN-401 Gene Therapy for PKP2-Associated Arrhythmogenic Right…
AppLovin Announces Third Quarter 2026 Financial Results
AppLovin posted record third quarter earnings: net income grew 72% year-over-year to $1.44 billion on record revenue of $2.18 billion, up 55%…
Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates
Ribupatide oral global Phase 3 program expected to begin in 1H 2027 following completion of End-of-Phase 2 meeting with FDA
Mativ Announces Third Quarter 2026 Results
Rayonier, L.P.
STABILIS SOLUTIONS ANNOUNCES THIRD QUARTER 2026 RESULTS
Snap Inc. Announces Third Quarter 2026 Financial Results
Third quarter revenue increased 14% year-over-year to $1,722 million
HMH Holding Inc. Announces Third Quarter 2026 Results
Design Therapeutics Announces Third Quarter 2026 Financial Results and Recent Business Updates
DT-216P2 Anticipated Milestones: Registrational Plan Update in Q4 2026 and 12-Week RESTORE-FA Data in Q1 2027